無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

腹部大動脈ステントグラフト:医療機器のパイプライン分析

Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2018

発行 GlobalData 商品コード 374725
出版日 ページ情報 英文 138 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.94円で換算しております。
Back to Top
腹部大動脈ステントグラフト:医療機器のパイプライン分析 Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2018
出版日: 2018年06月14日 ページ情報: 英文 138 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発中の腹部大動脈ステントグラフトのパイプライン製品情報について分析し、治験/製品開発の全体的な進行状況や、段階別・地域別・分野別の詳細動向、企業別・製品別の詳細情報 (治験の進行段階、開始/終了時期、認証見通しなど)、昨今の製品開発・資本取引の動きなどを盛り込んでお届けいたします。

第1章 目次

第2章 イントロダクション

  • 腹部大動脈ステントグラフトの概要

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:認証時期別 (推定)
  • 現在進行中の治験

第4章 腹部大動脈ステントグラフト:開発中のパイプライン製品 (企業別)

  • 腹部大動脈ステントグラフトの開発企業:パイプライン製品 (開発段階別)
  • 腹部大動脈ステントグラフト:開発段階別のパイプライン製品の一覧

第5章 腹部大動脈ステントグラフトの開発企業・製品の概要

  • BiFlow Medical Ltd
    • パイプライン製品および進行中の治験の概要
  • Bolton Medical, Inc.
  • Cardiatis SA
  • Cardiovate
  • Cook Medical Incorporated
  • Cordis Corporation
  • Cytograft Tissue Engineering, Inc.
  • Endologix, Inc.
  • Endoluminal Sciences Pty Ltd.
  • EndoSpan Ltd
  • Lombard Medical Technologies Inc.
  • Lombard Medical Technologies Limited
  • Medtronic plc
  • MicroPort Scientific Corporation
  • St. Jude Medical, Inc.
  • TriVascular, Inc.
  • University of Limerick
  • Venus MedTech
  • W. L. Gore & Associates, Inc.

第6章 腹部大動脈ステントグラフト:昨今の市場動向 (全72件)

第7章 付録

図表一覧

図表

List of Tables

1.1 List of Tables

  • Table 1: Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development 10
  • Table 2: Abdominal Aortic Stent Grafts - Pipeline Products by Territory 11
  • Table 3: Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path 13
  • Table 4: Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date 14
  • Table 5: Abdominal Aortic Stent Grafts - Ongoing Clinical Trials 15
  • Table 6: Abdominal Aortic Stent Grafts Companies - Pipeline Products by Stage of Development 16
  • Table 7: Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development 17
  • Table 8: Altura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 9: Altura Endograft System - Product Status 19
  • Table 10: Altura Endograft System - Product Description 19
  • Table 11: Altura Medical Inc - Ongoing Clinical Trials Overview 20
  • Table 12: Altura Endograft System - Kissing Endografts for Peripheral AAA Exclusion (ELEVATEInternational) 21
  • Table 13: Altura Endograft System - Multi-center Observational Post-market Real World Registry 21
  • Table 14: Altura Endograft System - The Altura AAA Endograft Safety and Feasibility Study For Exclusion of Abdominal Aortic Aneurysms 21
  • Table 15: BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 16: Stainless Steel Nitinol Two-Way Shape Memory Stent - Product Status 22
  • Table 17: Stainless Steel Nitinol Two-Way Shape Memory Stent - Product Description 22
  • Table 18: Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 19: Zenith p-Branch - Product Status 23
  • Table 20: Zenith p-Branch - Product Description 23
  • Table 21: Cook Medical Inc - Ongoing Clinical Trials Overview 24
  • Table 22: Zenith p-Branch - Evaluation of Visceral Function Following Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR) Using Branch Stent-Grafts 25
  • Table 23: Zenith p-Branch - Study Assessing Safety and Effectiveness of Perivisceral Aortic Aneurysm Treatment with the Zenith Fenestrated AAA Endovascular Graft and the Zenith p-Branch and the Effects on Organ and Extremity Perfusion 25
  • Table 24: Zenith p-Branch - Zenith p-Branch Multi-center Study 25
  • Table 25: Zenith p-Branch - Zenith p-Branch Pivotal Study 26
  • Table 26: Zenith p-Branch - Zenith p-Branch: Single-center Study 26
  • Table 27: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 28: INCRAFT AAA Stent Graft - Product Status 27
  • Table 29: INCRAFT AAA Stent Graft - Product Description 27
  • Table 30: Cordis Corp - Ongoing Clinical Trials Overview 28
  • Table 31: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft Stent Graft System in Subjects With Abdominal Aortic Aneurysms: INSPIRATION 29
  • Table 32: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Post Approval Study of the INCRAFT Abdominal Aortic Aneurysm (AAA) Stent Graft System in Subjects with Abdominal Aortic Aneurysms 29
  • Table 33: INCRAFT AAA Stent Graft - Compassionate Use of the Incraft AAA Stent Graft System 29
  • Table 34: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 35: LifeJacket AAA Stent Graft - Product Status 30
  • Table 36: LifeJacket AAA Stent Graft - Product Description 30
  • Table 37: Endologix Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 38: AFX2 Bifurcated Endograft System - Product Status 31
  • Table 39: AFX2 Bifurcated Endograft System - Product Description 32
  • Table 40: AFX3 - Product Status 32
  • Table 41: AFX3 - Product Description 32
  • Table 42: AFX4 - Product Status 33
  • Table 43: AFX4 - Product Description 33
  • Table 44: Nellix CHEVAS - Product Status 33
  • Table 45: Nellix CHEVAS - Product Description 34
  • Table 46: Nellix EVAS System - Product Status 34
  • Table 47: Nellix EVAS System - Product Description 34
  • Table 48: Nellix With Snorkels - Product Status 35
  • Table 49: Nellix With Snorkels - Product Description 35
  • Table 50: Nellix2 AAA Endovascular System - Product Status 35
  • Table 51: Nellix2 AAA Endovascular System - Product Description 35
  • Table 52: Ovation Alto Abdominal Stent Graft System - Product Status 36
  • Table 53: Ovation Alto Abdominal Stent Graft System - Product Description 36
  • Table 54: Paravisceral System - Product Status 36
  • Table 55: Paravisceral System - Product Description 36
  • Table 56: Ventana 2 - Product Status 37
  • Table 57: Ventana 2 - Product Description 37
  • Table 58: Xpand BX Covered Stent - Product Status 37
  • Table 59: Xpand BX Covered Stent - Product Description 37
  • Table 60: Endologix Inc - Ongoing Clinical Trials Overview 38
  • Table 61: Nellix EVAS System - Multicenter, Observational, Registry to Assess Outcomes of Patients Treated With the CE Marked Nellix System for Endovascular Abdominal Aortic Aneurysm Repair 39
  • Table 62: Nellix EVAS System - Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System IDE Study: EVAS 2 Confirmatory IDE Study 39
  • Table 63: Nellix EVAS System - Prospective, Multicenter, Single Arm Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System: A Pivotal and Continued Access Study 39
  • Table 64: Nellix EVAS System - Study of a Sealing Type Stent-graft For Abdominal Aortic Aneurysm 40
  • Table 65: Xpand BX Covered Stent - Prospective, Multicenter, Single Arm Feasibility and Safety Study of the Endologix Fenestrated Stent Graft System for the Endovascular Repair of Juxtarenal/Pararenal (JAA/PAA) Aneurysms 41
  • Table 66: Nellix2 AAA Endovascular System - Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System IDE Study: EVAS 2 Confirmatory IDE Study 42
  • Table 67: Ovation Alto Abdominal Stent Graft System - Expanding Patient Applicability with Polymer Sealing Ovation Alto Stent Graft IDE Study 43
  • Table 68: Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 69: Stent-Graft With Adhesive Delivery Platform - Product Status 44
  • Table 70: Stent-Graft With Adhesive Delivery Platform - Product Description 44
  • Table 71: Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 72: In Situ Weldable Hybrid Stent - Product Status 45
  • Table 73: In Situ Weldable Hybrid Stent - Product Description 45
  • Table 74: Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 75: Abdominal Aortic Aneurysm Stent Graft - Product Status 46
  • Table 76: Abdominal Aortic Aneurysm Stent Graft - Product Description 46
  • Table 77: Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 78: Ankura II AAA Stent Graft - Product Status 47
  • Table 79: Ankura II AAA Stent Graft - Product Description 47
  • Table 80: Iliac Bifurcation Stent Graft System - Product Status 48
  • Table 81: Iliac Bifurcation Stent Graft System - Product Description 48
  • Table 82: Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 83: Aorfix Plus Endovascular Stent Graft - Product Status 49
  • Table 84: Aorfix Plus Endovascular Stent Graft - Product Description 49
  • Table 85: FEVAR - Product Status 50
  • Table 86: FEVAR - Product Description 50
  • Table 87: Lombard Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 88: Aorfix Flexible Stent Graft System - Product Status 51
  • Table 89: Aorfix Flexible Stent Graft System - Product Description 51
  • Table 90: Low Profile Stent Graft - Product Status 52
  • Table 91: Low Profile Stent Graft - Product Description 52
  • Table 92: Lombard Medical Technologies Ltd - Ongoing Clinical Trials Overview 53
  • Table 93: Aorfix Flexible Stent Graft System - AAA Registry: Clinical Outcomes of Highly Angulated Anatomy Treated with the Aorfix Stent Graft (ARCHYTAS) 54

List of Figures

1.2 List of Figures

  • Figure 1: Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development 10
  • Figure 2: Abdominal Aortic Stent Grafts - Pipeline Products by Territory 11
  • Figure 3: Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path 13
  • Figure 4: Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date 14
  • Figure 5: Abdominal Aortic Stent Grafts - Ongoing Clinical Trials 15
目次
Product Code: GDME0575EPD

GlobalData's Medical Devices sector report, "Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2018" provides an overview of Abdominal Aortic Stent Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Abdominal Aortic Stent Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Abdominal Aortic Stent Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Abdominal Aortic Stent Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Abdominal Aortic Stent Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 8

2 Introduction 9

  • 2.1 Abdominal Aortic Stent Grafts Overview 9

3 Products under Development 10

  • 3.1 Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development 10
  • 3.2 Abdominal Aortic Stent Grafts - Pipeline Products by Territory 11
  • 3.3 Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path 13
  • 3.4 Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date 14
  • 3.5 Abdominal Aortic Stent Grafts - Ongoing Clinical Trials 15

4 Abdominal Aortic Stent Grafts - Pipeline Products under Development by Companies 16

  • 4.1 Abdominal Aortic Stent Grafts Companies - Pipeline Products by Stage of Development 16
  • 4.2 Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development 17

5 Abdominal Aortic Stent Grafts Companies and Product Overview 19

  • 5.1 Altura Medical Inc Company Overview 19
    • 5.1.1 Altura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.2 BiFlow Medical Ltd Company Overview 22
    • 5.2.1 BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.3 Cook Medical Inc Company Overview 23
    • 5.3.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.4 Cordis Corp Company Overview 27
    • 5.4.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.5 Cytograft Tissue Engineering Inc (Inactive) Company Overview 30
    • 5.5.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.6 Endologix Inc Company Overview 31
    • 5.6.1 Endologix Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.7 Endoluminal Sciences Pty Ltd. Company Overview 44
    • 5.7.1 Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.8 Hadassah Medical Center Company Overview 45
    • 5.8.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.9 Kawasumi Laboratories Inc Company Overview 46
    • 5.9.1 Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.10 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 47
    • 5.10.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.11 Lombard Medical Technologies Inc. Company Overview 49
    • 5.11.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.12 Lombard Medical Technologies Ltd Company Overview 51
    • 5.12.1 Lombard Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.13 Medtronic plc Company Overview 55
    • 5.13.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.14 MicroPort Scientific Corp Company Overview 58
    • 5.14.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.15 St. Jude Medical LLC Company Overview 59
    • 5.15.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.16 Terumo Aortic Company Overview 60
    • 5.16.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.17 TriVascular Inc Company Overview 67
    • 5.17.1 TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview 67
  • 5.18 University of Colorado Denver Company Overview 72
    • 5.18.1 University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.19 University of Limerick Company Overview 73
    • 5.19.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 73
  • 5.20 Venus MedTech Company Overview 74
    • 5.20.1 Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.21 W. L. Gore & Associates Inc Company Overview 75
    • 5.21.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview 75

6 Abdominal Aortic Stent Grafts- Recent Developments 78

  • 6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 78
  • 6.2 May 22, 2018: UT Southwestern surgeons among world's first to repair aortic arch aneurysm with leading-edge technique 80
  • 6.3 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC 81
  • 6.4 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow 82
  • 6.5 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 82
  • 6.6 May 04, 2018: Ross Harvey named new director of global Customer Support & Delivery at Cook Medical 82
  • 6.7 May 02, 2018: Endologix Announces First Quarter 2018 Financial Results 83
  • 6.8 May 02, 2018: Endologix Names John Onopchenko As Chief Executive Officer 84
  • 6.9 Apr 26, 2018: Vizient Names David F. Ertel as New Chief Financial Officer 84
  • 6.10 Apr 25, 2018: Endovascular Aneurysm Sealing (EVAS) with Nellix System Associated with Higher Survival than Traditional Endovascular Aneurysm Repair (EVAR) in New Study 85
  • 6.11 Apr 25, 2018: LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%) 86
  • 6.12 Apr 25, 2018: 2018 Vizient Connections Summit to Focus on Maximizing Supply Chain Operations and Pharmacy Performance 87
  • 6.13 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 87
  • 6.14 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 88
  • 6.15 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 88
  • 6.16 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results 90
  • 6.17 Mar 21, 2018: Endospan Receives CE Mark for HORIZON EVAR System Based on Robust Clinical and Pivotal Data to Treat Abdominal Aortic Aneurysm (AAA) 91
  • 6.18 Mar 19, 2018: Endologix Reports Positive Results from Global ENCORE Analysis with Polymer Endovascular Aneurysm Repair (EVAR) Using Ovation Abdominal Stent Graft Systems 91
  • 6.19 Mar 05, 2018: Endologix Announces Enrollment of the First Patient in EVAS2 IDE Clinical Study of the Nellix EndoVascular Aneurysm Sealing System 91
  • 6.20 Feb 21, 2018: LeMaitre Reports Net Income Of $4.3mm In Q4 2017 92
  • 6.21 Feb 21, 2018: Endologix Reports Fourth Quarter and Fiscal Year 2017 Financial Results 93
  • 6.22 Feb 21, 2018: Endologix Announces Resignation Of John McDermott As Chief Executive Officer 94
  • 6.23 Feb 12, 2018: Vizient Named as a 2018 World's Most Ethical Company by the Ethisphere Institute 94
  • 6.24 Feb 08, 2018: MicroPort Endovascular Hercules Series Products Gain Regulatory Approval in Colombia 95
  • 6.25 Feb 08, 2018: Joint development agreement for Japan's first abdominal aortic aneurysm stent graft 96
  • 6.26 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 97
  • 6.27 Feb 05, 2018: Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study 97
  • 6.28 Feb 05, 2018: Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study 97
  • 6.29 Feb 04, 2018: Byron Jobe Leads Vizient as New President and CEO 98
  • 6.30 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 98
  • 6.31 Jan 29, 2018: Endologix Names Greg Morrow As Chief Marketing Officer 99
  • 6.32 Jan 29, 2018: Endologix Appoints Greg Morrow as Chief Marketing Officer 100
  • 6.33 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 100
  • 6.34 Jan 24, 2018: Medtronic Launches ENCHANT Study to Evaluate ChEVAR Parallel Graft Technique with the Endurant(TM) II/IIs Stent Graft System 102
  • 6.35 Jan 11, 2018: Vizient to Share GPO Insights on Medical Device Cybersecurity at Jan. 16 Conference 103
  • 6.36 Jan 08, 2018: Altura Endograft System Granted CFDA Green-Path 104
  • 6.37 Jan 08, 2018: MicroPort Endovascular Attends CEC 2017 104
  • 6.38 Jan 08, 2018: Lombard Medical Announces Update on its Loan and Security Agreement 106
  • 6.39 Jan 03, 2018: First Patient Enrolled in Investigational Study of the GORE EXCLUDER Conformable AAA Endoprosthesis with ACTIVE CONTROL System 106
  • 6.40 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 107
  • 6.41 Dec 13, 2017: Terumo Constructs a New Building in Yamaguchi, Japan To Strengthen Production Operations in Interventional Systems 108
  • 6.42 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 109
  • 6.43 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 111
  • 6.44 Nov 07, 2017: Endologix Reports Third Quarter 2017 Financial Results 112
  • 6.45 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 113
  • 6.46 Oct 31, 2017: Lombard Medical Reports First Half and Third Quarter 2017 Financial Results 114
  • 6.47 Oct 26, 2017: LeMaitre Q3 2017 Sales $24.8mm (+7%), Record EPS $0.25 (+49%) 116
  • 6.48 Oct 19, 2017: Endologix Appoints John Onopchenko as Chief Operating Officer 116
  • 6.49 Oct 10, 2017: Terumo Provides Update on Impact from Hurricane Maria 117
  • 6.50 Oct 09, 2017: Medtronic Endurant II/IIs Stent Graft System Receives FDA Approval to Treat Short Neck Anatomies When Used with Heli-FX EndoAnchor System 117
  • 6.51 Oct 06, 2017: Endologix Receives IDE Approval for the EVAS2 Confirmatory Clinical Study to Evaluate the Nellix EndoVascular Aneurysm Sealing System 118
  • 6.52 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 119
  • 6.53 Oct 03, 2017: Vizient Names New President and CEO 120
  • 6.54 Oct 02, 2017: Celebrating the 20th Anniversary of the GORE EXCLUDER Device 121
  • 6.55 Sep 26, 2017: Vizient Announces Stephen Downey in Newly Created Role of Group Senior Vice President of Supply Chain Operations 122
  • 6.56 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California 122
  • 6.57 Sep 21, 2017: Endologix Announces CE Mark Approval for the Nellix EndoVascular Aneurysm Sealing System with the Refined Indications for Use 123
  • 6.58 Sep 20, 2017: Lombard Medical Appoints Jonathan Hornsby as Vice President, Sales & Marketing 124
  • 6.59 Sep 13, 2017: New Five-Year Gender Subset Data from the Medtronic Engage Registry Presented in VIVA Late Breaking Trials 124
  • 6.60 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY 125
  • 6.61 Sep 11, 2017: Vizient Deeply Concerned that Proposed CMS Rules Will Harm Hospitals and Negatively Impact Patient Care 127
  • 6.62 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 127
  • 6.63 Aug 17, 2017: Endologix Announces Positive Clinical Results from the LEOPARD Clinical Study 130
  • 6.64 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 131
  • 6.65 Aug 02, 2017: Endologix Reports Second Quarter 2017 Financial Results 131
  • 6.66 Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%) 132
  • 6.67 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 133
  • 6.68 Jul 21, 2017: Bolton Medical Announces the First Implant in the TREO Global Registry 133
  • 6.69 Jul 07, 2017: MPSC New COO Glendy Wang on Board 134

7 Appendix 135

  • 7.1 Methodology 135
  • 7.2 About GlobalData 138
  • 7.3 Contact Us 138
  • 7.4 Disclaimer 138
Back to Top